Prospects of antigen-specific therapy in type 1 diabetes mellitus
Type 1 diabetes mellitus is commonly recognized as an autoimmune disease characterized by progressive destruction of pancreatic ?-beta-cells. Progress in diagnostics at preclinical stage is accompanied with active development of preventive measures. So far, there are no specific therapeutic agents a...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN RU |
| Publicado: |
Endocrinology Research Centre
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/dcc7b58ce30f498f8bd52c9a5e94510c |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:dcc7b58ce30f498f8bd52c9a5e94510c |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:dcc7b58ce30f498f8bd52c9a5e94510c2021-11-14T09:00:17ZProspects of antigen-specific therapy in type 1 diabetes mellitus2072-03512072-037810.14341/2072-0351-5534https://doaj.org/article/dcc7b58ce30f498f8bd52c9a5e94510c2012-12-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5534https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Type 1 diabetes mellitus is commonly recognized as an autoimmune disease characterized by progressive destruction of pancreatic ?-beta-cells. Progress in diagnostics at preclinical stage is accompanied with active development of preventive measures. So far, there are no specific therapeutic agents approved for clinical practice. However, ongoing large-scale studies have outlined some promising solutions, antigen-specific immunotherapy being one of them.Tatiana Vasil'evna NikonovaYulia Viktorovna AlekseevaEndocrinology Research Centrearticlegad65hsp60diamyddiapep277diabetes mellitus type 1vaccinationgad65hsp60insulindiamyddiapep277Nutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 15, Iss 4, Pp 28-32 (2012) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN RU |
| topic |
gad65 hsp60 diamyd diapep277 diabetes mellitus type 1 vaccination gad65 hsp60 insulin diamyd diapep277 Nutritional diseases. Deficiency diseases RC620-627 |
| spellingShingle |
gad65 hsp60 diamyd diapep277 diabetes mellitus type 1 vaccination gad65 hsp60 insulin diamyd diapep277 Nutritional diseases. Deficiency diseases RC620-627 Tatiana Vasil'evna Nikonova Yulia Viktorovna Alekseeva Prospects of antigen-specific therapy in type 1 diabetes mellitus |
| description |
Type 1 diabetes mellitus is commonly recognized as an autoimmune disease characterized by progressive destruction of pancreatic ?-beta-cells. Progress in diagnostics at preclinical stage is accompanied with active development of preventive measures. So far, there are no specific therapeutic agents approved for clinical practice. However, ongoing large-scale studies have outlined some promising solutions, antigen-specific immunotherapy being one of them. |
| format |
article |
| author |
Tatiana Vasil'evna Nikonova Yulia Viktorovna Alekseeva |
| author_facet |
Tatiana Vasil'evna Nikonova Yulia Viktorovna Alekseeva |
| author_sort |
Tatiana Vasil'evna Nikonova |
| title |
Prospects of antigen-specific therapy in type 1 diabetes mellitus |
| title_short |
Prospects of antigen-specific therapy in type 1 diabetes mellitus |
| title_full |
Prospects of antigen-specific therapy in type 1 diabetes mellitus |
| title_fullStr |
Prospects of antigen-specific therapy in type 1 diabetes mellitus |
| title_full_unstemmed |
Prospects of antigen-specific therapy in type 1 diabetes mellitus |
| title_sort |
prospects of antigen-specific therapy in type 1 diabetes mellitus |
| publisher |
Endocrinology Research Centre |
| publishDate |
2012 |
| url |
https://doaj.org/article/dcc7b58ce30f498f8bd52c9a5e94510c |
| work_keys_str_mv |
AT tatianavasilevnanikonova prospectsofantigenspecifictherapyintype1diabetesmellitus AT yuliaviktorovnaalekseeva prospectsofantigenspecifictherapyintype1diabetesmellitus |
| _version_ |
1718429617818173440 |